Phathom Pharmaceuticals, Inc.
PHAT
$10.58
-$0.21-1.95%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 129.97M | 135.16M | 149.57M | 212.32M | 297.26M |
| Total Receivables | 78.13M | 55.79M | 51.26M | 36.36M | 38.80M |
| Inventory | 5.52M | 3.61M | 3.43M | 3.17M | 3.21M |
| Prepaid Expenses | 15.35M | 13.23M | 14.62M | 13.06M | 20.87M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 228.97M | 207.78M | 218.88M | 264.90M | 360.13M |
|
|
|||||
| Total Current Assets | 228.97M | 207.78M | 218.88M | 264.90M | 360.13M |
| Net Property, Plant & Equipment | 3.67M | 3.85M | 2.12M | 1.74M | 2.09M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 26.51M | 28.66M | 29.23M | 27.57M | 16.10M |
| Total Assets | 259.15M | 240.29M | 250.22M | 294.21M | 378.32M |
|
|
|||||
| Total Accounts Payable | 4.98M | 1.08M | 4.01M | 11.62M | 10.51M |
| Total Accrued Expenses | 91.66M | 67.11M | 66.05M | 44.83M | 54.94M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 27.90M | 24.94M | 21.76M | 17.58M | 20.28M |
| Total Finance Division Other Current Liabilities | 7.50M | -- | -- | -- | -- |
| Total Other Current Liabilities | 7.50M | -- | -- | -- | -- |
| Total Current Liabilities | 132.04M | 93.12M | 91.82M | 74.03M | 85.73M |
|
|
|||||
| Total Current Liabilities | 132.04M | 93.12M | 91.82M | 74.03M | 85.73M |
| Long-Term Debt | 559.21M | 556.08M | 552.14M | 547.05M | 534.67M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.07M | 2.12M | 589.00K | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.00M | 11.50M | 11.50M | 11.50M | 11.50M |
| Total Liabilities | 697.32M | 662.82M | 656.05M | 632.58M | 631.90M |
|
|
|||||
| Common Stock & APIC | 1.05B | 1.04B | 1.03B | 1.02B | 1.01B |
| Retained Earnings | -1.48B | -1.46B | -1.43B | -1.36B | -1.26B |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -438.17M | -422.53M | -405.83M | -338.38M | -253.58M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -438.17M | -422.53M | -405.83M | -338.38M | -253.58M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -438.17M | -422.53M | -405.83M | -338.38M | -253.58M |
|
|
|||||